Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Genetic defects in CD40 ligand (CD40L), CD19, or CD81 lead to antibody deficiency, with reduced memory B cells and serum antibodies.
• The functional capacity of remaining B cells and antibodies in these patients is not well understood.

Purpose of the Study:

• To investigate why memory B cells and antibodies in CD19- and CD40L-deficient patients do not confer functional immunity.
• To elucidate the molecular mechanisms underlying impaired B-cell responses in these genetic deficiencies.

Main Methods:

• Detailed flow cytometry analysis of blood B cells from CD19-deficient patients (n=8), CD40L-deficient patients (n=8), and healthy controls (n=50).
• Molecular analysis of IgA and IgG transcripts, including somatic mutation analysis.
• Functional assessment of B-cell activation and DNA repair gene expression.

Main Results:

• CD19 and CD40L deficiencies reduced most memory B-cell subsets, with altered immunoglobulin transcripts showing fewer somatic mutations and reduced IgG2/IgA2 subclass usage.
• Impaired selection for antigen binding and against autoreactivity was observed, linked to differential DNA repair pathway activity (activation-induced cytidine deaminase, uracil-DNA glycosylase 2, mismatch repair).
• B-cell activation defects were partly attributed to transcriptional regulation of DNA repair genes.

Conclusions:

• Both B-cell antigen receptor (CD19) and CD40 signaling are crucial for selecting immunoglobulin reactivity.
• These pathways differentially regulate DNA repair mechanisms during somatic hypermutation.
• Together, CD19 and CD40L signaling shape the human in vivo antigen-experienced B-cell repertoire through coordinated DNA repair processes.